Long-Term Follow-Up of the Randomized GITMO/IIL Trial Comparing CHOP-Rituximab vs. High-Dose Therapy with Rituximab (R-HDS) in High Risk Follicular Lymphoma (Fl): Updated Results Suggest the Use of R-HDS as Salvage Treatment

M. LADETTO;F. DE MARCO;F. BENEDETTI;U. VITOLO;C. PATTI;A. RAMBALDI;A. PULSONI;M. MUSSO;A. M. LIBERATI;A. OLIVIERI;A. GALLAMINI;E. POGLIANI;D. ROTA SCALABRINI;V. CALLEA;DI RAIMONDO, FRANCESCO;V. PAVONE;A. TUCCI;S. CORTELAZZO;A. LEVIS;M. BOCCADORO;I. MAJOLINO;A. PILERI;A. M. GIANNI;R. PASSERA;P. CORRADINI;C. TARELLA

2007-01-01